There is no substitute for proven expertise when it comes to international law. That’s why leading media around the world so often turn to Harris Bricken for our insight.
“China is criminalizing what, in places like the United States, and most countries in the world, would be considered normal discourse,” Fred Rocafort, a legal expert on China and a former diplomat, told The Dispatch.
ReadWhile Daniel holds a strong opinion, his main intent is to create a conversation about the DEA’s role in our country and how drug use should be properly addressed.
ReadA U.S. Food and Drug Administration warning letter against a CBD company for making an unfounded health claim, for example, “is almost an invitation to a plaintiff’s lawyer to file a class action suit,” said Oregon cannabis attorney Jesse Mondry, co-chair of Harris Bricken’s dispute resolution/litigation practice group.
ReadSteve Dickinson, an attorney who works with foreign companies in China, tells CW, “Since all Chinese companies will be non-compliant, that means all Chinese companies will eventually be delisted. The value of the stock would be destroyed.”
ReadA U.S. Federal Food and Drug Administration warning letter against a CBD company for making an unfounded health claim, for example, “is almost an invitation to a plaintiff lawyer,” Mondry said.
Read“At the moment companies look to Hong Kong as a way of having one foot in China but keeping the other foot out of all the complications that doing business in mainland China brings,” said Fred Rocafort, a lawyer at Harris Bricken who has more than a decade of international legal experience, primarily in China, Vietnam and Thailand. “To the extent that you start moving in the direction of having, if not both feet, let’s say almost both feet in the mainland, that’s going to be a problem.”
Read
